Stock Analysis
- Australia
- /
- Medical Equipment
- /
- ASX:NAN
ASX November 2024 Stocks Estimated To Be Trading Below Fair Value
Reviewed by Simply Wall St
The Australian stock market recently experienced a downturn, with the ASX200 dropping to a seven-week low, driven largely by declines in the Health Care and Financials sectors. In such volatile conditions, identifying stocks that may be trading below their fair value can present potential opportunities for investors looking to capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Australia
Name | Current Price | Fair Value (Est) | Discount (Est) |
DUG Technology (ASX:DUG) | A$1.845 | A$3.48 | 47% |
Ansell (ASX:ANN) | A$30.91 | A$57.84 | 46.6% |
MLG Oz (ASX:MLG) | A$0.62 | A$1.15 | 46.2% |
Audinate Group (ASX:AD8) | A$8.99 | A$17.81 | 49.5% |
Megaport (ASX:MP1) | A$6.81 | A$13.42 | 49.3% |
IDP Education (ASX:IEL) | A$13.99 | A$27.37 | 48.9% |
Millennium Services Group (ASX:MIL) | A$1.145 | A$2.24 | 48.9% |
Smart Parking (ASX:SPZ) | A$0.73 | A$1.31 | 44.3% |
Energy One (ASX:EOL) | A$5.65 | A$11.04 | 48.8% |
Mineral Resources (ASX:MIN) | A$40.61 | A$79.07 | 48.6% |
Underneath we present a selection of stocks filtered out by our screen.
Infomedia (ASX:IFM)
Overview: Infomedia Ltd is a technology company that develops and supplies electronic parts catalogues, service quoting software, and e-commerce solutions for the automotive industry worldwide, with a market cap of A$532.16 million.
Operations: The company's revenue comes from its publishing segment, specifically periodicals, amounting to A$140.83 million.
Estimated Discount To Fair Value: 41.8%
Infomedia is trading at A$1.4, significantly below its estimated fair value of A$2.41, suggesting it is undervalued based on cash flows. The company's earnings grew by 32.4% over the past year and are forecast to grow significantly at 22% per year, outpacing the Australian market's growth rate. Despite a dividend not well covered by earnings and large one-off items impacting results, analysts agree on a potential price rise of 45.1%.
- Upon reviewing our latest growth report, Infomedia's projected financial performance appears quite optimistic.
- Dive into the specifics of Infomedia here with our thorough financial health report.
Mineral Resources (ASX:MIN)
Overview: Mineral Resources Limited, along with its subsidiaries, operates as a mining services company in Australia, Asia, and internationally with a market cap of A$7.68 billion.
Operations: The company's revenue segments include A$16 million from Energy, A$1.41 billion from Lithium, A$2.58 billion from Iron Ore, and A$3.38 billion from Mining Services, along with A$19 million from Other Commodities.
Estimated Discount To Fair Value: 48.6%
Mineral Resources, trading at A$40.61, is significantly undervalued based on cash flows with an estimated fair value of A$79.07. Although its profit margins have decreased to 2.4% from 5.1% last year, earnings are expected to grow substantially at 38.8% annually over the next three years, outpacing the Australian market's growth rate of 12.3%. The company is exploring asset sales and partnerships to address its high net debt of A$4.4 billion and fund future projects like the Onslow iron ore project.
- Insights from our recent growth report point to a promising forecast for Mineral Resources' business outlook.
- Navigate through the intricacies of Mineral Resources with our comprehensive financial health report here.
Nanosonics (ASX:NAN)
Overview: Nanosonics Limited is an infection prevention company with global operations and a market capitalization of A$970.78 million.
Operations: The company's revenue primarily comes from its Healthcare Equipment segment, totaling A$170.01 million.
Estimated Discount To Fair Value: 37.2%
Nanosonics, trading at A$3.20, is undervalued with a fair value estimate of A$5.10, suggesting potential upside based on cash flows. Despite a drop from the S&P/ASX 200 Index and declining net income to A$12.97 million from A$19.88 million last year, earnings are forecast to grow significantly at 23.6% annually over the next three years, surpassing market averages. Recent board changes may affect strategic direction but do not alter its valuation appeal based on cash flow analysis.
- Our expertly prepared growth report on Nanosonics implies its future financial outlook may be stronger than recent results.
- Unlock comprehensive insights into our analysis of Nanosonics stock in this financial health report.
Turning Ideas Into Actions
- Embark on your investment journey to our 42 Undervalued ASX Stocks Based On Cash Flows selection here.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Nanosonics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ASX:NAN
Nanosonics
Operates as an infection prevention company globally.